Clinical Trial Update: Efficacy and Safety Study of Ozanimod in Relapsing Multiple Sclerosis [Phase 3]

View source ↗

Summary

Phase 3 trial update on OZanimod for relapsing multiple sclerosis reports efficacy and safety findings.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Relapsing Multiple Sclerosis

Drugs mentioned

• Ozanimod (ozanimod)

Snippet

Sponsor: Celgene | Conditions: Relapsing Multiple Sclerosis | Phase 3 | Status: COMPLETED | Results posted: 2021-02-11